The Gene Amplification Technologies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
A Rise in Demand for Genetic Data Collecting to Identify and Map Every Gene in the Human Genome Is Causing the Global Market to Expand
Gene amplification is the differential expansion of a certain region of the genome relative to the rest. Most species appear to engage in this process, which has been demonstrated to take place in both somatic and germline cells. Gene Amplification can have positive such as a growth or survival benefit or negative effects on the organism. It can be linked to normal developmental processes or occur as spontaneous genetic events. Somatic cell gene amplification in human malignancies has lately received substantial research. Proto-oncogene amplification may cause or contribute to the development of tumours. The amplified gene may occasionally serve as a viable target for cancer treatment. It mentions the growth of a certain DNA from a very little volume. A rise in demand for genetic data collecting to identify and map every gene in the human genome is causing the global market to expand. The global market for gene amplification technology is being driven by the widespread acceptance of specific cancer therapies. Human Genome Projects continue to be the primary factor driving the market for gene amplification technology (HGP).
The Growing Adoption of Customised Medicine, and Expanding Research in Molecular Diagnostics and Genomics Are the Key Market Drivers
The arrival of fresh and cutting-edge products, the growing adoption of customised medicine, and expanding research in molecular diagnostics and genomics are the key market drivers. In the near future, it is projected that rising genomics investments by pharmaceutical and biotechnology businesses would significantly fuel the industry. The biotechnology industry has recently seen a considerable shift toward novel pharmaceuticals and therapies, medicines based on genome sequencing, and technological developments, which has fuelled market expansion. The commercial adoption of gene multiplication techniques has been affected by improvements in molecular diagnostic tools such as NGS, droplet digital PCR, and genome-wide sequencing with respect to reproducibility, accuracy, and timeframe. The industry for gene multiplication technology has also been boosted by international projects like the Africa Pathogen Genomics Initiative (Africa PGI).
What Questions Should You Ask before Buying a Market Research Report?
How is the gene amplification technologies market evolving?
What is driving and restraining the gene amplification technologies market?
How will each gene amplification technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
How will the market shares for each gene amplification technologies submarket develop from 2023 to 2033?
What will be the main driver for the overall market from 2023 to 2033?
Will leading gene amplification technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
Who are the leading players and what are their prospects over the forecast period?
What are the gene amplification technologies projects for these leading companies?
How will the industry evolve during the period between 2023 and 2033? What are the implications of gene amplification technologies projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the gene amplification technologies market?
Where is the gene amplification technologies market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the gene amplification technologies market today, and over the next 10 years:
Our 425-page report provides 176 tables and 190 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the gene amplification technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising gene amplification technologies prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Market Segment by Sample Type
Single Cell
Formalin-Fixed & Paraffin-Embedded (FFPE)
Market Segment by End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End-Users
Market Segment by Business Type
Gene Amplification Kits & Reagents
Gene Amplification Instruments
Gene Amplification Services
Gene Amplification Ancillaries
Market Segment by Application
Hybridization Application
Whole Genome Amplification
Exome Sequencing Amplification
SNP Genotyping Arrays
Array CGH
Market Segment by Technology
PCR-based Amplification
Loop-mediated Isothermal Amplification
Nucleic Acid Sequence Based Amplification
Strand Displacement Amplification
Multiple Displacement Amplification
Other Technology
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
U.S.
Canada
Europe
Germany
Spain
United Kingdom
France
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
South Africa
Rest of Middle East & Africa
The report also includes profiles and for some of the leading companies in the Gene Amplification Technologies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
4BASEBIO AG
Abbott Laboratories
Agilent Technologies, Inc.
Ambion Inc.
Bayer Pharmaceutics AG
Becton Dickinson and Co.
Bio-Rad Laboratories
Danaher Corporation
Illumina Inc.
LGC Group
Merck KGaA
MyBioSource
Nanjing Vazyme Biotech Co.
New England Biolabs
PerkinElmer Inc.
Promega Corporation
Qiagen N.V.
Silicon Biosystems
Takara Bio Inc.
Yikang Inc.
Overall world revenue for Gene Amplification Technologies Market, 2023 to 2033 in terms of value the market will surpass US$4,853 million in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Gene Amplification Technologies Market, 2023 to 2033 report help you?
In summary, this 420+ page report provides you with the following knowledge:
Revenue forecasts to 2033 for Gene Amplification Technologies Market, 2023 to 2033 Market, with forecasts for application, technology, sample type, business type, end-user and company size, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2033 for four regional and 20 key national markets - See forecasts for the Gene Amplification Technologies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Gene Amplification Technologies Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Gene Amplification Technologies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
1.1 Objectives of the Study 1.2 Introduction to Gene Amplification Technologies Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report for? 1.7 Research Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Reports 1.10 About
2 Executive Summary
3 Premium Insights
3.1 Geographical Snapshot: Global Gene Amplification Technologies Market 3.2 Technology Segment: Market Attractiveness Index 3.3 Sample Type Segment: Market Attractiveness Index 3.4 End-User Segment: Market Attractiveness Index 3.5 Business Type Segment: Market Attractiveness Index 3.6 Application Segment: Market Attractiveness Index
4 Market Overview
4.1 Key Findings 4.2 Market Dynamics 4.2.1 Market Driving Factors 4.2.2 Market Restraining Factors 4.2.3 Market Opportunities 4.3 Supply Chain Overview 4.4 Value Chain Overview 4.4.1 Cold Chain 4.5 Recent Trends and Developments 4.6 COVID-19 Impact Analysis 4.7 Porter’s Five Forces Analysis 4.7.1 Supplier Power 4.7.2 Buyer Power 4.7.3 Competitive Rivalry 4.7.4 Threat from Substitutes 4.7.5 Threat of New Entrants 4.8 PESTLE Analysis 4.8.1 Political Factors 4.8.2 Economic Factors 4.8.3 Social Factors 4.8.4 Technological Factors 4.8.5 Legal Factors 4.8.6 Environmental Factors
5 Global Gene Amplification Technologies Market Analysis by Application
5.1 Key Findings 5.2 Global Market Outlook 5.3 Region Segment Growth Prospects 5.4 Global Gene Amplification Technologies Market Share by Region, 2023 & 2033 5.5 Global Gene Amplification Technologies Market Share Forecast 5.5.1 Pre-COVID-19 Market Scenario 5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 5.6 Global Pharma Contract Sales Market by Region Size Estimation and Forecast 5.6.1 Pre-COVID-19 Market Scenario 5.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Gene Amplification Technologies Market Analysis by Technology
6.1 Key Findings 6.2 Global Technology Market Outlook 6.3 Global Gene Amplification by Technology Market Attractiveness Index 6.4 Regional Market Size Estimation and Forecast 6.5 Amplification based on PCR 6.5.2 Global PCR-based Amplification Market Forecast 6.5.3 Global Cleavable Linkers Market Forecast by Region 6.6 Loop-mediated Isothermal Amplification 6.7 Global Loop-mediated Isothermal Amplification Market Forecast 6.7.1 Global Loop-mediated Isothermal Amplification Market Forecast by Region 6.8 Nucleic Acid Sequence Based Amplification 6.8.1 Nucleic Acid Sequence Based Amplification Market Forecast 6.8.2 Global Nucleic Acid Sequence Based Amplification Market Forecast by Region 6.9 Strand Displacement Amplification 6.8.3 Strand Displacement Amplification Market Forecast 6.8.4 Global Strand Displacement Amplification Market Forecast by Region 6.10 Multiple Displacement Amplification 6.10.1 Multiple Displacement Amplification Market Forecast 6.8.5 Global Multiple Displacement Amplification Market Forecast by Region 6.11 Other Technology Amplification 6.8.6 Other Technology Amplification Market Forecast
7 Global Gene Amplification Technologies Market Analysis by Sample Type
7.1 Key Findings 7.2 Global Sample Type Market Outlook 7.2.1 Global Gene Amplification by Sample Type Market Attractiveness Index 7.3 Global Gene Amplification Technologies Market by Sample Type 7.4 Single Cell 7.4.1 Global Single Cell Market Forecast 7.4.2 Global Single Cell Market Forecast by Region 7.5 Formalin-Fixed, Paraffin-Embedded (FFPE) 7.5.1 Global FFPE Market Forecast 7.5.2 Global FFPE Market Forecast by Region
8 Global Gene Amplification Technologies Market Analysis by End-User
8.1 Key Findings 8.2 Global End-User Market Outlook 8.2.1 Global Gene Amplification by End-User Market Attractiveness Index 8.3 Global Gene Amplification Technologies Market by End-User Antigen 8.4 Pharmaceutical & Biotechnological Companies 8.4.1 Global Pharmaceutical & Biotechnological Companies Market Forecast 8.4.2 Global Pharmaceutical & Biotechnological Companies Market Forecast by Region 8.5 Academic & Research Institute 8.5.1 Global Academic & Research Institute Market Forecast 8.5.2 Global Academic & Research Institute Market Forecast by End-User
9 Global Gene Amplification Technologies Market Analysis by Business Type
9.1 Key Findings 9.2 Global Business Type Market Outlook 9.2.1 Global Gene Amplification by Business Type Market Attractiveness Index 9.3 Global Gene Amplification Technologies Market by Business Type 9.4 Kits & Reagents 9.4.1 Global Kits & Reagents Market Forecast 9.4.2 Global Kits & Reagents Market by Region 9.5 Instruments 9.5.1 Global Instruments Market Forecast 9.5.2 Global Instruments Market by Region 9.6 Services 9.6.1 Global Services Market Forecast 9.6.2 Global Services Market by Region 9.7 Ancillaries 9.7.1 Global Ancillaries Market Forecast 9.7.2 Global Ancillaries Market by Region
10 North America Market Analysis
10.1 Key Findings 10.2 Overview 10.2.2 North America Gene Amplification Technologies Market Attractiveness Index 10.3 North America Gene Amplification Technologies Market Size and Forecast by Value 10.4 North Gene Amplification Technologies Market Size Estimation and Forecast by Country 10.5 North America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type 10.6 North America Gene Amplification Technologies Market Size Estimation and Forecast by End-User 10.7 North America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type 10.8 North America Gene Amplification Technologies Market Size Estimation and Forecast by Application 10.9 North America Gene Amplification Technologies Market Size Estimation and Forecast by Technology 10.10 US Market 10.10.1 The US Government's Foreign Investment Risk 10.10.2 The American Pharmaceutical Research and Manufacturers 10.11 Canada Market 10.11.1 Control of Laboratory-Developed Tests 10.11.2 Drug-related Expenses
11 Europe Market Analysis
11.1 Key Findings 11.2 Overview 11.3 Europe Gene Amplification Technologies Market Attractiveness Index 11.5 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Country 11.4 Europe Gene Amplification Technologies Market Size and Forecast by Value 11.6 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type 11.7 Europe Gene Amplification Technologies Market Size Estimation and Forecast by End-User 11.8 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Business Type 11.9 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Application 11.10 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Technology 11.2 Germany Market 11.2.1 Germany Has a Robust and Broad Market 11.2.2 Inventive IVD industry 11.3 UK Market 11.3.1 UK Guidelines for Microbiology Examinations (UK SMIs) 11.3.2 The NHS Has Made Clinically-Directed Genetic Testing Available for Molecular Genetic Analysis 11.4 France Market 11.4.1 Molecular Diagnostics Market Expansion in France 11.4.2 Foreign Organisations Investing in France 11.5 Italy Market 11.5.1 Italian Pharmaceuticals' Advantage 11.5.2 Nucleic Acid Amplification Technology's (NAT) Effects in Italy 11.6 Spain Market 11.6.1 Spanish Clinical Genetics and Genomics 11.6.2 Expansion of Spain's pharmaceutical and R&D Industries 11.15 Rest of Europe Market Analysis
12 Asia-Pacific Market Analysis
12.1 Key Findings 12.2 Overview 12.2.1 The Commercial Effect of Polymerase Chain Reactions 12.2.2 Asia-Pacific Market for Gene Therapy 12.3 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index 12.4 Asia-Pacific Gene Amplification Technologies Market Size and Forecast by Value 12.5 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Country 12.6 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type 12.7 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by End-User 12.8 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Business Type 12.9 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Application 12.10 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Technology 12.3 China Market 12.3.1 China's Molecular Diagnostics Market Is Going to Expand At a Faster Rate Than That of Other Nations 12.3.2 Market Segment Analysis for Molecular Diagnostics 12.4 India Market 12.4.1 Advancements in POC Diagnostic Technology 12.4.2 India's Genome Engineering Technology Regulations 12.5 Japan Market 12.5.1 Japan's Ability to Use Genomic Medicine 12.5.2 Developments in Japanese Genetic Testing Regulation 12.14 South Korea Market 12.5.3 Pharmaceutical Industry Development in South Korea 12.6 Australia Market 12.6.1 Nucleic Acid Amplification Assays for Active Mycobacterial Infection 12.6.2 Australia Is a Dynamic Centre for the Biological Sciences with a Worldwide Reach 12.7 Rest of Asia-Pacific Market Analysis
13 Middle East & Africa Market Analysis
13.1 Key Findings 13.2 Overview 13.2.1 MENA's Expanding Pharmaceutical Industry 13.2.2 MENA's Regulatory Environment 13.3 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index 13.4 Middle East & Africa Gene Amplification Technologies Market Size and Forecast by Value 13.5 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Country 13.6 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type 13.7 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by End-User 13.8 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Business Type 13.9 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Application 13.10 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Technology 13.3 South Africa Market Analysis 13.3.1 On the African Continent, South Africa Has the Biggest Life Sciences Market 13.4 Saudi Arabia Market Analysis 13.4.1 Pharmacy Research and Development of Saudi Arabia 13.4.2 Rules and Regulations 13.5 Turkey Market Analysis 13.5.1 Turkish Regulatory Authority 13.5.2 Updates to the Recommendations for PCR Testing 13.6 Rest of Middle East and Africa Market Analysis
14 Latin America Market Analysis
14.1 Key Findings 14.2 Overview 14.2.1 Significantly Raise in Latin American Pharmaceutical Industry 14.2.2 Comparison with Other Industries and Analysis of the Direct, Indirect, and Induced Impacts 14.3 Latin America Gene Amplification Technologies Market Attractiveness Index 14.4 Latin America Gene Amplification Technologies Market Size and Forecast by Value 14.5 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Country 14.6 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type 14.7 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by End-User 14.8 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type 14.9 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Application 14.10 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Technology 14.11 Brazil Market 14.2.3 Brazil's Loop-Mediated Isothermal Amplification (LAMP) Assay Development and Clinical Evaluation for the Diagnosis of Human Visceral Leishmaniasis 14.2.4 Brazilian Government Regulations and Policies 14.3 Mexico Market 14.3.1 Mexican Pharmaceutical Firms Take Advantage of Market Circumstances 14.13 Rest of Latin America Market Analysis
15 Competitive Landscape
15.2 Key Business Strategy Analysis- Acquisition 15.3 Key Business Strategy Analysis- Agreement 15.4 Key Business Strategy Analysis- Collaboration 15.5 Key Business Strategy Analysis- Expansion 15.6 Key Business Strategy Analysis- Investment 15.7 Key Business Strategy Analysis- New Product Launch 15.8 Key Business Strategy Analysis- Partnership 15.9 Key Business Strategy Analysis- Development 15.10 Key Business Strategy Analysis- Joint Venture
16 Company Profiles
16.1 Merck KGaA 16.1.2 Company Snapshot 16.1.3 Company Overview 16.1.4 Financial Analysis 16.1.5 Product Benchmarking 16.1.6 Strategic Outlook 16.2 4BASEBIO AG 16.2.1 Company Snapshot 16.2.2 Company Overview 16.2.3 Financial Analysis 16.2.4 Product Benchmarking 16.2.5 Strategic Outlook 16.3 Abbott Laboratories (U.S.) 16.3.1 Company Snapshot 16.3.2 Company Overview 16.3.3 Financial Analysis 16.3.4 Product Benchmarking 16.3.5 Strategic Outlook 16.4 Agilent Technologies, Inc. (U.S.) 16.4.1 Company Snapshot 16.4.2 Company Overview 16.4.3 Financial Analysis 16.4.4 Product Benchmarking 16.4.5 Strategic Outlook 16.5 Ambion Inc. 16.5.1 Company Snapshot 16.5.2 Company Overview 16.5.3 Product Benchmarking 16.5.4 Strategic Outlook 16.6 Bayer Pharmaceutics 16.6.1 Company Snapshot 16.6.2 Company Overview 16.6.3 Financial Analysis 16.6.4 Product Benchmarking 16.6.5 Strategic Outlook 16.7 Becton Dickinson and Co. 16.7.1 Company Snapshot 16.7.2 Company Overview 16.8.4 Product Benchmarking 16.7.3 Financial Analysis 16.7.4 Product Benchmarking 16.7.5 Strategic Outlook 16.8 Bio-Rad Laboratories 16.8.1 Company Snapshot 16.8.2 Company Overview 16.8.3 Financial Analysis 16.8.5 Strategic Outlook 16.9 MyBioSource 16.9.1 Company Snapshot 16.9.2 Company Overview 16.9.3 Product Benchmarking 16.9.4 Strategic Outlook 16.10 Danaher Corporation 16.10.1 Company Snapshot 16.10.2 Company Overview 16.10.3 Financial Analysis 16.10.4 Product Benchmarking 16.10.5 Strategic Outlook 16.11 Illumina Inc. 16.11.1 Company Snapshot 16.11.2 Company Overview 16.11.3 Financial Analysis 16.11.4 Product Benchmarking 16.11.5 Strategic Outlook 16.12 LGC Group 16.12.1 Company Snapshot 16.12.2 Company Overview 16.12.3 Product Benchmarking 16.12.4 Strategic Outlook 16.13 Nanjing Vazyme Biotech Co. 16.13.1 Company Snapshot 16.13.3 Financial Analysis 16.13.4 Product Benchmarking 16.13.5 Strategic Outlook 16.14 New England Biolabs 16.14.1 Company Snapshot 16.14.2 Company Overview 16.14.3 Product Benchmarking 16.14.4 Strategic Outlook 16.15 PerkinElmer Inc. 16.15.1 Company Snapshot 16.15.3 Financial Analysis 16.15.4 Product Benchmarking 16.15.5 Strategic Outlook 16.16 Promega Corporation 16.16.1 Company Snapshot 16.16.2 Company Overview 16.16.3 Product Benchmarking 16.16.4 Strategic Outlook 16.17 Qiagen N.V. 16.17.1 Company Snapshot 16.17.3 Financial Analysis 16.17.4 Product Benchmarking 16.17.5 Strategic Outlook 16.18 Silicon Biosystems 16.18.1 Company Snapshot 16.18.2 Company Overview 16.18.3 Product Benchmarking 16.18.4 Strategic Outlook 16.19 Takara Bio Inc. 16.19.1 Company Snapshot 16.19.2 Company Overview 16.19.3 Financial Analysis 16.19.4 Product Benchmarking 16.19.5 Strategic Outlook 16.20 Yikang Inc. 16.20.1 Company Snapshot 16.20.2 Company Overview 16.20.3 Product Benchmarking 16.20.4 Strategic Outlook
17 Conclusion and Recommendations
17.1 Concluding Remarks from 17.2 Recommendations for Market Players
Companies Mentioned
4BASEBIO AG
Abbott Laboratories
Agilent Technologies, Inc.
Ambion Inc.
Bayer Pharmaceutics AG
Becton Dickinson and Co.
Bio-Rad Laboratories
Danaher Corporation
Illumina Inc.
LGC Group
Merck KGaA
MyBioSource
Nanjing Vazyme Biotech Co.
New England Biolabs
PerkinElmer Inc.
Promega Corporation
Qiagen N.V.
Silicon Biosystems
Takara Bio Inc.
Yikang Inc.
4D Molecular Therapeutics
Abeona Therapeutics
Actus Therapeutics
Adrenas
Adverum Biotechnologies
Akouos
Amicus Therapeutics
Apollo Therapeutics
Aruvant Sciences
Aspa Therapeutics
Audentes
AVROBIO
Axovant Sciences Ltd
BioVec Pharma
Brainvectis SAS
Catalyst Biosciences
CavoGene Lifesciences
Copernicus Therapeutics
CRISPR Therapeutics AG
Editas Medicine
Enzo Biochem
Errant Gene Therapeutics
Esteve Pharmaceuticals SA
Excision BioTherapeutics
Exonics Therapeutics
Expression Therapeutics
Fibrocell Science
Freeline Therapeutics
Gemini Therapeutics
Generation Bio Corp.
Genethon SA
GenSight Biologics SA
Gyroscope Therapeutics
Hemera Biosciences
Holostem Terapie Avanzate Srl
Homology Medicines
Horama SA
Immusoft Corp.
iTherapeutics Corp.
IVERIC bio
Krystal Biotech
Lamellar Biomedical
Logicbio Therapeutics
Lysogene
Lysogene SAS/ Sarepta Therapeutics
MeiraGTx
Milo Biotechnology
Mustang Bio
NanoScope Technologies
NeuExcell Therapeutics
Nightstar Therapeutics/
Passage Bio
Therapeutics
PTC Therapeutics
Renova Therapeutics
Rocket Pharmaceuticals
Rubius Therapeutics
SanBio Co
Tamid Bio
Telocyte
Temprian Therapeutics
Tocagen
Tolerion
Ultragenyx Pharmaceutical
ViroMed Co Ltd
Vivet Therapeutics SAS
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
Food and Drug Administration (US FDA)
Gene Therapy Net
Indian Drug Manufacturer's Association (IDMA)
Informa UK Limited
IntechOpen
International Society of Pharmaceutical Engineering (IPSE)
JOURNAL OF GENERAL VIROLOGY
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer's Association (KPMA)
Massachusetts Medical Society
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
*Required Information
This website uses cookies to ensure you get the best experience. Learn more